作者
Takahiro Nishio, Ronglin Hu, Yukinori Koyama, Shuang Liang, Sara B Rosenthal, Gen Yamamoto, Daniel Karin, Jacopo Baglieri, Hsiao-Yen Ma, Jun Xu, Xiao Liu, Debanjan Dhar, Keiko Iwaisako, Kojiro Taura, David A Brenner, Tatiana Kisseleva
发表日期
2019/9/1
期刊
Journal of Hepatology
卷号
71
期号
3
页码范围
573-585
出版商
Elsevier
简介
Background & Aims
Chronic liver injury often results in the activation of hepatic myofibroblasts and the development of liver fibrosis. Hepatic myofibroblasts may originate from 3 major sources: hepatic stellate cells (HSCs), portal fibroblasts (PFs), and fibrocytes, with varying contributions depending on the etiology of liver injury. Here, we assessed the composition of hepatic myofibroblasts in multidrug resistance gene 2 knockout (Mdr2−/−) mice, a genetic model that resembles primary sclerosing cholangitis in patients.
Methods
Mdr2−/− mice expressing a collagen-GFP reporter were analyzed at different ages. Hepatic non-parenchymal cells isolated from collagen-GFP Mdr2−/− mice were sorted based on collagen-GFP and vitamin A. An NADPH oxidase (NOX) 1/4 inhibitor was administrated to Mdr2−/− mice aged 12–16 weeks old to assess the therapeutic approach of targeting oxidative stress in cholestatic injury …
引用总数
20192020202120222023202441524242715